LS Snapshot Cover

Life Sciences References Valuation Snapshot

10 Jun 2020

European healthcare indices and the COVID-19 impact

The COVID-19 pandemic has dramatically impacted many aspects of life. The extent of the effects still needs to be fully understood. But some impacts to the Life Sciences M&A market are already visible. Across all industries many transactions have been put on hold, as parties are concentrating on the continuity of their businesses. While some of those deals will be closed later this year, many will be stalled. The shortage of debt financing, the investment controlling regulation by the German government and purchase price disputes might reduce the number of transactions even more. In this worldwide downturn of the economy, Life Sciences companies will not be immune, but they show more resilience than other sectors.

The trend of Life Sciences companies focusing on their core businesses is now more visible than ever, as we see increased spin-offs and divestitures. We also expect increasing institutional investments in the Life Sciences sector. With less targets on the market, those opportunities will become more competitive.

As the pandemic is forcing us to go online, the trend towards digitalisation will see an immense acceleration. Changes that for long have seemed impossible due to strict regulations and cultural aversions, are now happening, including telehealth and sick leave notes via phone. Patients and providers have learned to manage the distance and use digital tools. The enormous costs burdening the providers as a consequence of the shutdowns will further drive digitalisation to dramatically increase productivity.

COVID -19 will eventually lead to a re-thinking of supply chains. China holds a central role as manufacturer, producing 90% of active pharmaceutical ingredients, thus leading to fear of shortages and dependencies. Some countries have limited their export of medical products. Businesses in the future will be required to have detailed planning on how to overcome short term supply issues. This aspect will also have a strong impact on the pricing in M&A transactions.

Most Medtech and pharma companies remained stable throughout the pandemic, while healthcare provider businesses are having difficulties. With many specialty doctor’s offices being closed, and hospitals concentrating on COVID-19 patients and emergencies rather than performing revenue-driving surgeries, the healthcare provider segment sees decreasing revenues and increasing losses. The full extent of the SARS CoV-2 virus on the Life Sciences industry will have to be evaluated at the end of the pandemic, but with the exception of provider businesses M&A activities will remain on high levels at comparably high prices.

Download the full snapshot

Team

Picture of Jessica Algner
Jessica Algner

Assistant

Telephone: +49 30 809 33 47-12

LinkedIn

@

Picture of Polina Amini
Polina Amini

Senior Associate

Telephone: +49 40 300 836-14

LinkedIn

@

Picture of Markus Augustsson
Markus Augustsson

Head of Equity Research

Telephone: +46 76 235 03 20

LinkedIn

@

Picture of Agata Barsallo
Agata Barsallo

Office Management & Accounting

Telephone: +44 20 8017 6020

@

Picture of Caroline Berglund
Caroline Berglund

Head of Equity Sales

Telephone: +46 73 382 10 82

LinkedIn

@

Picture of Anders Bo
Anders Bo

Managing Partner

Telephone: +45 4199 8252

LinkedIn

@

Picture of Ulf Boberg
Ulf Boberg

Senior Advisor Life Sciences

Telephone: +46 73 312 44 90

LinkedIn

@

Picture of Manfred Drax
Manfred Drax

Partner

Telephone: +49 89 255 49 53-15

LinkedIn

@

Picture of Anders Elgemyr
Anders Elgemyr

Managing Partner

Telephone: +46 70 496 18 15

LinkedIn

@

Picture of Sebastian Fischer
Sebastian Fischer

Director

Telephone: +49 89 255 49 53-12

LinkedIn

@

Picture of Daniel Garlipp
Daniel Garlipp

Managing Partner

Telephone: +49 40 300 836-19

LinkedIn

@

Picture of Philip Goldhahn
Philip Goldhahn

Vice President

Telephone: +49 40 300 836-21

LinkedIn

@

Picture of Thorsten Grandt
Thorsten Grandt

Vice President

Telephone: +49 30 809 33 47-20

LinkedIn

@

Picture of Johan Heigard
Johan Heigard

Vice President

Telephone: +46 70 246 99 88

LinkedIn

@

Picture of Caroline Heintz
Caroline Heintz

Senior Associate

Telephone: +46 707 40 68 58

@

Picture of Maurice Hinrichs
Maurice Hinrichs

Associate

Telephone: +49 40 300 836-20

LinkedIn

@

Picture of Arnold Holle
Arnold Holle

Managing Partner

Telephone: +44 20 80176020

LinkedIn

@

Picture of Lars Johansen
Lars Johansen

IT&Telecom Expert

@

Picture of Elaine Kelly
Elaine Kelly

Head of Marketing

Telephone: +49 40 300 836 18

LinkedIn

@

Picture of Anna-Lena Kickbusch
Anna-Lena Kickbusch

Office Management & Accounting

Telephone: +49 40 300 836 10

LinkedIn

@

Picture of Morten Kjærulff
Morten Kjærulff

Partner

Telephone: +45 2634 9031

LinkedIn

@

Picture of Mischa Krause
Mischa Krause

Director

Telephone: +49 40 300 836-24

LinkedIn

@

Picture of Steffen Leckert
Steffen Leckert

Managing Partner

Telephone: +49 89 255 49 53 26

LinkedIn

@

Picture of Malve Liebig
Malve Liebig

Senior Associate

Telephone: +49 89 255 49 53-18

LinkedIn

@

Picture of Erik Lundberg
Erik Lundberg

Partner

Telephone: +46 73 850 35 59

LinkedIn

@

Picture of Eva Macha
Eva Macha

Office Management & PA to Michael Moritz

Telephone: +49 30 809 33 47-10

LinkedIn

@

Picture of Mandy May
Mandy May

Head of Operations

Telephone: +49 30 809 33 47 16

LinkedIn

@

Picture of Mirja Meyer
Mirja Meyer

Office Management & Accounting

Telephone: +49 40 300 836 10

@

Picture of Mark Miller
Mark Miller

Managing Partner

Telephone: +49 40 300 836-11

LinkedInXING

@

Picture of Michael Moritz
Michael Moritz

Managing Partner

Telephone: +49 30 809 33 47-13

LinkedIn

@

Picture of Bertil Nilsson
Bertil Nilsson

Senior Equity Analyst

Telephone: +46 70 434 90 03

LinkedIn

@

Picture of Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telephone: +45 4199 8251

LinkedIn

@

Picture of Richard Ramanius
Richard Ramanius

Associate Equity Analyst

Telephone: +46 73 539 66 99

LinkedIn

@

Picture of Anika Schaefer
Anika Schaefer

Office Management & HR

Telephone: +49 89 255 495 310

@

Picture of Alexander Schleppegrel
Alexander Schleppegrel

Associate

Telephone: +45 2621 0543

LinkedIn

@

Picture of Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Partner

Telephone: +49 89 255 49 53-17

@

Picture of Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telephone: +49 89 255 49 53-11

LinkedIn

@

Picture of Gregor Steins
Gregor Steins

Associate

Telephone: +49 40 300 836-15

LinkedIn

@

Picture of Jon Tingling
Jon Tingling

Senior Associate

Telephone: +44 77 1347-8286

LinkedIn

@

Picture of Sybille de Vegvar
Sybille de Vegvar

Business Development & Marketing

Telephone: +44 20 8017 6017

@

Picture of Oskar Wollert
Oskar Wollert

Vice President

Telephone: +46 761 71 11 60

@

Picture of Nils Zettelmeyer
Nils Zettelmeyer

Director

Telephone: +49 30 809 33 47-25

LinkedIn

@

Picture of Andreas Zetzsche
Andreas Zetzsche

Partner

Telephone: +49 30 809 3347 33

@

Picture of Gerrit Zwarg
Gerrit Zwarg

Senior Associate

Telephone: +49 40 300 836-28

LinkedIn

@